Ganfeng Lithium Group Co., Ltd.

DB:39EA Stock Report

Market Cap: €9.9b

Ganfeng Lithium Group Valuation

Is 39EA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 39EA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 39EA (€2.88) is trading above our estimate of fair value (€0.33)

Significantly Below Fair Value: 39EA is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 39EA?

Key metric: As 39EA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 39EA. This is calculated by dividing 39EA's market cap by their current revenue.
What is 39EA's PS Ratio?
PS Ratio3.9x
SalesCN¥21.21b
Market CapCN¥74.79b

Price to Sales Ratio vs Peers

How does 39EA's PS Ratio compare to its peers?

The above table shows the PS ratio for 39EA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.4x
EVK Evonik Industries
0.5x2.2%€8.2b
2NF Syensqo
1.1x4.2%€7.5b
SY1 Symrise
3x5.5%€14.8b
1COV Covestro
0.8x4.3%€10.8b
39EA Ganfeng Lithium Group
3.9x14.0%€74.8b

Price-To-Sales vs Peers: 39EA is expensive based on its Price-To-Sales Ratio (3.9x) compared to the peer average (1.4x).

Price to Sales Ratio vs Industry

How does 39EA's PS Ratio compare vs other companies in the DE Chemicals Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
2HRA H&R GmbH KGaA
0.1x2.7%US$132.33m
NSAK OTI Greentech
0.03xn/aUS$594.68k
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
39EA 3.9xIndustry Avg. 1.0xNo. of Companies5PS00.40.81.21.62+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 39EA is expensive based on its Price-To-Sales Ratio (3.9x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is 39EA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

39EA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3.9x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: 39EA is expensive based on its Price-To-Sales Ratio (3.9x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Compañía de Minas BuenaventuraA

US$3.1b

Engages in the exploration, development, construction, and operation of mineral processing business.

MBU

US$11.40

7D

-0.9%

1Y

37.3%

Arkema

€5.6b

Manufactures and sells specialty chemicals and advanced materials worldwide.

V1S

€74.30

7D

-4.7%

1Y

-20.2%

Central Asia Metals

UK£276.3m

Operates as a base metals producer.

9C3

UK£1.86

7D

-0.5%

1Y

-4.1%